SCHEMBL7226136

SCHEMBL7226136

Cc1ccn2c(-c3cccc(-c4cccc(-c5noc(C)n5)c4)c3)cnc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.56
GABRG2 P18507 6/20 0.55
GABRB3 P28472 6/20 0.55
GABRA1 P14867 5/20 0.55
GABRA3 P34903 4/20 0.55
GABRA5 P31644 3/20 0.55
GABRA2 P47869 3/20 0.55
NTRK1 P04629 2/20 0.38
PIM1 P11309 2/20 0.38
CHEK1 O14757 1/20 0.38
CDK2 P24941 1/20 0.38
CSNK2A1 P68400 1/20 0.38
BACE1 P56817 1/20 0.38
FLT3 P36888 1/20 0.38
DAO P14920 1/20 0.37
KDR P35968 1/20 0.36
CHRNA7 P36544 1/20 0.35
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227602 0.78 GABRG2 (0.64) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7234152 0.76 GABRA1 (0.60) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7226062 0.76 GABRG2 (0.62) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7232228 0.75 GABRG2 (0.61) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL13130238 0.75 L3MBTL1 (1.00) L3MBTL1CHRNA7MAPTTP53POLB
SCHEMBL7225665 0.74 GABRA1 (0.58) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7224559 0.74 GABRA1 (0.70) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7231394 0.73 GABRG2 (0.56) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7231846 0.73 GABRG2 (0.56) GABRG2GABRB3GABRA1GABRA3GABRA5
SCHEMBL7224413 0.72 GABRA1 (0.67) GABRG2GABRB3GABRA1GABRA3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642229-B2 Treatment of adverse neurological conditions MERCK SHARP & DOHME LTD. 2003-11-04 US claimed
US-6642229-B2 Treatment of adverse neurological conditions MERCK SHARP & DOHME LTD. 2003-11-04 US disclosed